Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Purple Biotech Q3 EPS $(0.27)

Purple Biotech (NASDAQ:PPBT) reported quarterly losses of $(0.27) per share.

byBill Haddad

November 8, 2022

1 minute read

Purple Biotech (NASDAQ:PPBT) reported quarterly losses of $(0.27) per share.

Twitter, Zoom Video And Some Other Big Stocks Moving Lower On Tuesday

By Lisa Levin

Today, 11:50 PM

GigaCloud Technology Inc. (NASDAQ: GCT) fell 29.9% to $29.01 after declining around 14% on Monday.

DLO

FDA
News

Health Canada Updates Pfizer/BioNTech COVID-19 Vaccine Label To Reflect Very Rare Reports Of Bell’s Palsy

By Benzinga Newsdesk

Today, 11:50 PM

-Reuters

BNTX

Goldman Sachs Initiates Coverage On TDCX with Buy Rating, Announces Price Target of $30.3

By Benzinga Newsdesk

Today, 11:50 PM

Goldman Sachs initiates coverage on TDCX (NYSE:TDCX) with a Buy rating and announces Price Target of $30.3.

TDCX

Civeo Q4 Adj. EPS $(0.90) Misses $(0.61) Estimate, Sales $162.19M Beat $145.96M Estimate

By Benzinga Newsdesk

Today, 11:50 PM

Civeo (NYSE: CVEO) reported quarterly losses of $(0.90) per share which missed the analyst consensus estimate of $(0.61) by 47.54 percent. This is a 255.17 percent decrease over earnings of $0.58 per share from the same period last year.

CVEO

Purple Biotech Q3 EPS $(0.27)

Related Posts

Twitter, Zoom Video And Some Other Big Stocks Moving Lower On Tuesday

Health Canada Updates Pfizer/BioNTech COVID-19 Vaccine Label To Reflect Very Rare Reports Of Bell’s Palsy

Goldman Sachs Initiates Coverage On TDCX with Buy Rating, Announces Price Target of $30.3

Civeo Q4 Adj. EPS $(0.90) Misses $(0.61) Estimate, Sales $162.19M Beat $145.96M Estimate